COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer
Oncomedicine · 2017
DOI: 10.7150/oncm.17020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Wolfgang Hohenforst-Schmidt und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hohenforst-Schmidt, W., Domvri, K., Zogas, N., Zarogoulidis, P., Petanidis, S., Kioseoglou, E., Zachariadis, G., Kakolyris, S., Porpodis, K., Gaga, M., Huang, H., Kontakiotis, T., & Zarogoulidis, K. (2017). COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer. Oncomedicine. https://doi.org/10.7150/oncm.17020
Vancouver
Hohenforst-Schmidt W, Domvri K, Zogas N, Zarogoulidis P, Petanidis S, Kioseoglou E, et al. COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer. Oncomedicine. 2017. doi:10.7150/oncm.17020
BibTeX
@article{HohenforstSchmidt2017,
author = {Hohenforst-Schmidt, Wolfgang and Domvri, Kalliopi and Zogas, Nikolaos and Zarogoulidis, Paul and Petanidis, Savvas and Kioseoglou, Efrosini and Zachariadis, George and Kakolyris, Stylianos and Porpodis, Konstantinos and Gaga, Mina and Huang, Haidong and Kontakiotis, Theodor and Zarogoulidis, Konstantinos},
title = {COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer},
journal = {Oncomedicine},
year = {2017},
doi = {10.7150/oncm.17020}
}
EUVIMED